Taking Treatment from the Lab to the Clinic: Rishi Singh from Cleveland Clinic
OCTOBER 25, 2016
In many, if not most cases, there can be a break in the chain between researchers and the doctors they are developing treatments for. When that divide does not exist it can mean more direct access for doctors and patients to the latest treatments even in the development stages.
Rishi Singh, MD, from the Cleveland Clinic considers himself to be fortunate enough to use his clinic as his lab where he is able to help patients with a variety of eye conditions. While his patients present with any number of issues Singh said one of his main areas of focus is the trials of treatments in development for diabetic macular edema and age-related macular degeneration. While there are several medications available for these conditions Singh said they are working to find new options which can last longer and be more effective than those currently on the market.